LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

Kodu・Aktsiate loetelu・CorMedix Inc

CorMedix Inc

Suletud

SektorTervishoid

6.91 -4.16

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.8

Max

7.21

Põhinäitajad
By Trading Economics
Sissetulek	89M 109M
Müük	65M 104M
P/E Sektori keskmine	3.262 66.845
Kasumimarginaal	104.112
Töötajad	64
EBITDA	37M 57M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+89.6% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-300M 568M
Eelmine avamishind	11.07
Eelmine sulgemishind	6.91

Uudiste sentiment

By Acuity

100%

333 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. märts 2026, 18:43 UTC

Uudisväärsed sündmused

Fed's Kashkari Says Too Soon To Know Inflation Impact From Middle East Conflict

3. märts 2026, 17:33 UTC

Omandamised, ülevõtmised, äriostud

Ziff Davis to Sell Connectivity Division to Accenture for $1.2 Billion -- Update

3. märts 2026, 23:45 UTC

Market Talk

Nikkei May Fall on Continued Concerns About Energy Costs -- Market Talk

3. märts 2026, 23:44 UTC

Market Talk

Uudisväärsed sündmused

Gold Rises on Possible Dip-Buying Amid Ongoing Middle East Conflict -- Market Talk

3. märts 2026, 23:25 UTC

Market Talk

Bannerman Energy Likely to Raise Less Equity for Uranium Projects -- Market Talk

3. märts 2026, 23:25 UTC

Market Talk

Global Energy Roundup: Market Talk

3. märts 2026, 22:38 UTC

Uudisväärsed sündmused

Iran Conflict Pushes Europe Toward Fresh Energy Crisis -- WSJ

3. märts 2026, 22:16 UTC

Tulu

Berkshire Provides Scant Fourth-Quarter Financials. Investors Need to Do Their Own Calculations. -- Barrons.com

3. märts 2026, 22:09 UTC

Tulu

Century Aluminum Changed Historical Method of Proportionately Consolidating Jamalco Production Assets to a Full Consolidation

3. märts 2026, 22:06 UTC

Tulu

Century Aluminum: Accounting Change for 2023 and 2024 Doesn't Impact Net Income Attributable to Century Stockholders

3. märts 2026, 22:05 UTC

Tulu

Century Aluminum Initially Concluded That an Accounting Change Was Immaterial, SEC Staff Disagreed With Company's Materiality Conclusion

3. märts 2026, 22:03 UTC

Tulu

Century Aluminum to Restate Certain Results in Connection Wtih Accounting Change for Jamalco

3. märts 2026, 21:50 UTC

Market Talk

Uudisväärsed sündmused

Tech, Media & Telecom Roundup: Market Talk

3. märts 2026, 21:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

3. märts 2026, 21:45 UTC

Uudisväärsed sündmused

The Iran War Puts the Fed's Rate-Cut Timeline in Doubt -- Barrons.com

3. märts 2026, 21:37 UTC

Tulu

EVgo Stock Rises as Earnings Defy EV Slump. The Rest of 2026 Doesn't Look So Rosy. -- Barrons.com

3. märts 2026, 21:26 UTC

Uudisväärsed sündmused

Freeport McMoRan Stock Slides as the Mideast Conflict Hits Commodities -- Barrons.com

3. märts 2026, 20:31 UTC

Market Talk

Uudisväärsed sündmused

U.S. Natural Gas Gains on Middle East Turmoil, Weather Outlook -- Market Talk

3. märts 2026, 20:04 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Pull Back as Trump Offers Shipping Protection -- Market Talk

3. märts 2026, 19:17 UTC

Market Talk

Uudisväärsed sündmused

Gold and Silver Drop as Energy Surges -- Market Talk

3. märts 2026, 18:43 UTC

Tulu

Berkshire CEO Abel Is Fond of Financial Metric Similar to One Criticized by Buffett -- Barrons.com

3. märts 2026, 18:29 UTC

Market Talk

Uudisväärsed sündmused

Global Energy Roundup: Market Talk

3. märts 2026, 18:29 UTC

Market Talk

Uudisväärsed sündmused

Norsk Hydro Announces Stoppage of Qatar Aluminum Smelter -- Market Talk

3. märts 2026, 18:22 UTC

Uudisväärsed sündmused

Fed's Kashkari on March Projections: Had a Lot of Confidence Up Until a Few Days Ago

3. märts 2026, 18:22 UTC

Uudisväärsed sündmused

Fed's Kashkari: Too Soon to Know Impact Iran Conflict Will Have on Inflation

3. märts 2026, 18:17 UTC

Market Talk

Uudisväärsed sündmused

Strait of Hormuz Standstill Keeps Bid in Oil Futures -- Market Talk

3. märts 2026, 18:14 UTC

Tulu

How Long Can Anthropic Play Defense? -- WSJ

3. märts 2026, 17:41 UTC

Uudisväärsed sündmused

Exxon Is Down Since the Iran Conflict. These Energy Stocks Are Bigger Winners. -- Barrons.com

3. märts 2026, 17:36 UTC

Uudisväärsed sündmused

Iran Conflict is Starting to Boost Gasoline Prices -- Update

3. märts 2026, 17:28 UTC

Omandamised, ülevõtmised, äriostud

Tinicum, Blackstone to Make Decision on Offer By End of Day March 31

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

89.6% tõus

12 kuu keskmine prognoos

Keskmine 13.67 USD 89.6%

Kõrge 15 USD

Madal 13 USD

Põhineb 4 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

333 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.